Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Pre-flight Evaluation of Adult Patients With Cystic Fibrosis

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Oslo University Hospital
ClinicalTrials.gov Identifier:
NCT01569880
First received: March 30, 2012
Last updated: NA
Last verified: March 2012
History: No changes posted
  Purpose

The purpose of the study is to investigate the relationship between hypoxemia achieved during Hypoxia Altitude Simulation test and sea level values of pulmonary function, arterial blood gases, pulse oximetry and cardiopulmonary exercise test variables. In addition, to study the effect of slow walk in a hypoxic environment, comparable to slow walking along the aisle.


Condition
Cystic Fibrosis

Study Type: Observational
Study Design: Observational Model: Case-Only
Time Perspective: Prospective
Official Title: Pre-flight Evaluation of Adult Patients With Cystic Fibrosis

Resource links provided by NLM:


Further study details as provided by Oslo University Hospital:

Enrollment: 30
Study Start Date: January 2006
Study Completion Date: December 2008
Primary Completion Date: December 2008 (Final data collection date for primary outcome measure)
  Eligibility

Ages Eligible for Study:   17 Years to 80 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

Adult patients with cystic fibrosis

Criteria

Inclusion Criteria:

  • Cystic fibrosis
  • > 16 years
  • Sputum test negative for Burkholderia cepacia and/or methicillin resistant Staphylococcus aureus

Exclusion Criteria:

  • Ongoing infection
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01569880

Locations
Norway
Oslo University Hospital, Ullevål
Oslo, Norway, 0450
Sponsors and Collaborators
Oslo University Hospital
Investigators
Principal Investigator: Bjørn Skrede, PhD MD Oslo University Hospital
  More Information

No publications provided

Responsible Party: Oslo University Hospital
ClinicalTrials.gov Identifier: NCT01569880     History of Changes
Other Study ID Numbers: CF-HAST-OUS
Study First Received: March 30, 2012
Last Updated: March 30, 2012
Health Authority: Norway: Regional Ethics Commitee

Keywords provided by Oslo University Hospital:
Blood gas response
Exercise
Gas exchange
Hypoxia altitude simulation test
Pulmonary function

Additional relevant MeSH terms:
Cystic Fibrosis
Fibrosis
Digestive System Diseases
Genetic Diseases, Inborn
Infant, Newborn, Diseases
Lung Diseases
Pancreatic Diseases
Pathologic Processes
Respiratory Tract Diseases

ClinicalTrials.gov processed this record on November 24, 2014